BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camafort M, Kario K. Hypertension, heart failure, and frailty in older people: A common but unclear situation. J Clin Hypertens (Greenwich) 2020;22:1763-8. [PMID: 32815630 DOI: 10.1111/jch.14004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mone P, Gambardella J, Pansini A, de Donato A, Martinelli G, Boccalone E, Matarese A, Frullone S, Santulli G. Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia. Cells 2021;10:2115. [PMID: 34440883 DOI: 10.3390/cells10082115] [Reference Citation Analysis]
2 Li CY, Lin WC, Lu CY, Chung YS, Cheng YC. Prevalence of pain in community-dwelling older adults with hypertension in the United States. Sci Rep 2022;12:8387. [PMID: 35589916 DOI: 10.1038/s41598-022-12331-0] [Reference Citation Analysis]
3 Camafort M, Formiga F. [Sacubitril-valsartan should also be the first choice to be evaluated in the elderly patient with heart failure with reduced ejection fraction]. Rev Esp Geriatr Gerontol 2021;56:67-8. [PMID: 33526274 DOI: 10.1016/j.regg.2020.12.006] [Reference Citation Analysis]
4 Acosta-Benito MÁ, Martín-Lesende I. [Frailty in primary care: Diagnosis and multidisciplinary management]. Aten Primaria 2022;54:102395. [PMID: 35700618 DOI: 10.1016/j.aprim.2022.102395] [Reference Citation Analysis]
5 Kasiakogias A, Rosei EA, Camafort M, Ehret G, Faconti L, Ferreira JP, Brguljan J, Januszewicz A, Kahan T, Manolis A, Tsioufis K, Weber T, von Lueder TG, Smiseth OA, Wachtell K, Kjeldsen SE, Zannad F, Mancia G, Kreutz R. Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension. J Hypertens 2021;39:1522-45. [PMID: 34102660 DOI: 10.1097/HJH.0000000000002910] [Reference Citation Analysis]
6 Micheli L, Mitidieri E, Turnaturi C, Vanacore D, Ciampi C, Lucarini E, Cirino G, Ghelardini C, Sorrentino R, Di Cesare Mannelli L, d'Emmanuele di Villa Bianca R. Beneficial Effect of H2S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin. Int J Mol Sci 2022;23:5955. [PMID: 35682634 DOI: 10.3390/ijms23115955] [Reference Citation Analysis]
7 Argano C, Natoli G, Mularo S, Nobili A, Monaco ML, Mannucci PM, Perticone F, Pietrangelo A, Corrao S. Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry. Healthcare (Basel) 2022;10:86. [PMID: 35052252 DOI: 10.3390/healthcare10010086] [Reference Citation Analysis]
8 Fujiwara T, Mcmanus R, Kario K. Management of hypertension in the digital era: Perspectives and future directions. Hipertensión y Riesgo Vascular 2022. [DOI: 10.1016/j.hipert.2022.01.004] [Reference Citation Analysis]
9 Laddu DR, Ozemek C, Sabbahi A, Severin R, Phillips SA, Arena R. Prioritizing movement to address the frailty phenotype in heart failure. Prog Cardiovasc Dis 2021;67:26-32. [PMID: 33556427 DOI: 10.1016/j.pcad.2021.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Camafort M, Valdez-tiburcio O, Wyss F. Hypertension and heart failure with preserved ejection fraction. A past, present, and future relationship. Hipertensión y Riesgo Vascular 2022. [DOI: 10.1016/j.hipert.2021.12.003] [Reference Citation Analysis]